These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31604139)

  • 21. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis.
    Sandmann F; Jit M; Andrews N; Buckley HL; Campbell H; Ribeiro S; Sile B; Stowe J; Tessier E; Ramsay M; Amirthalingam G; Choi YH
    Vaccine; 2021 Jul; 39(32):4500-4509. PubMed ID: 34183204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas.
    Rutstein SE; Siedhoff MT; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL; Wheeler SB
    J Minim Invasive Gynecol; 2016 Feb; 23(2):223-33. PubMed ID: 26475764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trial-based cost-effectiveness analysis of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) versus DSAEK.
    Simons RWP; Dickman MM; van den Biggelaar FJHM; Dirksen CD; Van Rooij J; Remeijer L; Van der Lelij A; Wijdh RHJ; Kruit PJ; Nuijts RMMA
    Acta Ophthalmol; 2019 Dec; 97(8):756-763. PubMed ID: 31025804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis.
    Manning VL; Kaambwa B; Ratcliffe J; Scott DL; Choy E; Hurley MV; Bearne LM
    Rheumatology (Oxford); 2015 Feb; 54(2):302-9. PubMed ID: 25173349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cost-effectiveness of a proportionate parenting programme for primary caregivers and their child: an economic evaluation using evidence from the E-SEE Trial.
    Cox E; Walker S; Blower S; Sampaio F; Bywater T; Richardson G
    BMC Health Serv Res; 2022 Jun; 22(1):814. PubMed ID: 35739551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial.
    Becker F; Dakin HA; Reed SD; Li Y; Leal J; Gustavson SM; Wittbrodt E; Hernandez AF; Gray AM; Holman RR
    Diabetes Res Clin Pract; 2022 Jan; 183():109152. PubMed ID: 34813910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of Corticosteroid Nasal Spray vs Surgical Therapy in Patients With Severe to Extreme Anatomical Nasal Obstruction.
    Teti VP; Akdagli S; Most SP
    JAMA Facial Plast Surg; 2016 May; 18(3):165-70. PubMed ID: 26747790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analyzing cost-effectiveness of ulnar and median nerve transfers to regain forearm flexion.
    Wali AR; Park CC; Brown JM; Mandeville R
    Neurosurg Focus; 2017 Mar; 42(3):E11. PubMed ID: 28245686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An economic evaluation of the All New Zealand Acute Coronary Syndrome Quality Improvement Registry programme-subanalyses for Māori (ANZACS-QI 42).
    Lee P; Zomer E; Liew D
    N Z Med J; 2020 May; 133(1514):16-32. PubMed ID: 32379736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial.
    Schoenbaum M; Unützer J; Sherbourne C; Duan N; Rubenstein LV; Miranda J; Meredith LS; Carney MF; Wells K
    JAMA; 2001 Sep; 286(11):1325-30. PubMed ID: 11560537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.
    Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME;
    BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative physiotherapy is cost-effective for preventing pulmonary complications after major abdominal surgery: a health economic analysis of a multicentre randomised trial.
    Boden I; Robertson IK; Neil A; Reeve J; Palmer AJ; Skinner EH; Browning L; Anderson L; Hill C; Story D; Denehy L
    J Physiother; 2020 Jul; 66(3):180-187. PubMed ID: 32680742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Economic Impact of Acetabular Labral Tears: A Cost-effectiveness Analysis Comparing Hip Arthroscopic Surgery and Structured Rehabilitation Alone in Patients Without Osteoarthritis.
    Lodhia P; Gui C; Chandrasekaran S; Suarez-Ahedo C; Dirschl DR; Domb BG
    Am J Sports Med; 2016 Jul; 44(7):1771-80. PubMed ID: 27190068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
    Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A
    Value Health; 2010; 13(2):196-208. PubMed ID: 19878493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of Financial Incentives for Patients and Physicians to Manage Low-Density Lipoprotein Cholesterol Levels.
    Pandya A; Asch DA; Volpp KG; Sy S; Troxel AB; Zhu J; Weinstein MC; Rosenthal MB; Gaziano TA
    JAMA Netw Open; 2018 Sep; 1(5):e182008. PubMed ID: 30646152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients.
    Tew M; Clarke P; Thursky K; Dalziel K
    Pharmacoeconomics; 2019 Jul; 37(7):931-941. PubMed ID: 30864067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health gains, costs and cost-effectiveness of a population-based screening programme for abdominal aortic aneurysms.
    Nair N; Kvizhinadze G; Jones GT; Rush R; Khashram M; Roake J; Blakely A
    Br J Surg; 2019 Jul; 106(8):1043-1054. PubMed ID: 31115915
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.